Infecting the Blind with Sight | Gene Therapy News

UC Berkeley professor John Flannery is using a combination of genetic tools and viral delivery systems to treat diseased photoreceptors. Already his work has contributed to an experimental treatment that has returned some vision to more than two dozen people. Flannery is now refining these techniques and expanding their application, work that will return sight to affected patients.

Click here for selected publications.